Sanjay Shah, MD
Pain Medicine · Spring House, PANPI 1770558413
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (45.4%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 60 manufacturers reported payments, led by Surgentec at 44.1% of the total. Reporting peaked in 2023 at $18,956 and has fallen 80.0% since, to $3,796 in 2025. Among pain medicine clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,284 payments — averaging $49.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Surgentec$28K
- Abbott$12K
- Vertos Medical, Inc.$5K
- Collegium Pharmaceutical, Inc.$3K
- Boston Scientific$3K
- MML US, Inc.$2K
- plus $12K from 54 others
Across 1 payment — averaging $1050.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Nalu Medical, Inc.$1K
What the payments were for
- Royalty or licence$5,4319%
- Consulting fees$12,80020%
- Travel & lodging$14,68023%
- Food & beverage$28,90245%
- Education$1,8403%
- Gifts$00%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ION Facet Screw System$10,495
- TiLink$10,495
- ION Facet Screw$9,026
- ION$5,431
- mild Device Kit$3,986
- Intracept$1,433
- 3D GraftRasp System$1,267
- ReActiv8$1,160
- HA MINUTEMAN G3-R$1,031
- Superion ISS$724
- PROCLAIM$383
- LIBERTY SI$329
- WaveWriter Alpha Prime 16$231
- Senza$128
- Vascepa$125
- Omnia$125
- INFINITY$123
- INCEPTIV$116
- Proclaim Family of SCS IPGs$107
How this compares
$63,652 in reported general payments places this provider in the 95th percentile of 294 pain medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 94 | $70,140 |
| PercocetOxycodone Hcl/Acetaminophen | 12 | $55,706 |
| Xtampza ErOxycodone Myristate | 88 | $51,229 |
| BelbucaBuprenorphine Hcl | 44 | $38,879 |
| MovantikNaloxegol Oxalate | 93 | $38,738 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,658 | $34,700 |
| RelistorMethylnaltrexone Bromide | 12 | $30,274 |
| Oxycodone Hcl | 1,289 | $26,696 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 539 | $14,975 |
| Fentanyl | 148 | $14,178 |
| Morphine Sulfate ErMorphine Sulfate | 554 | $11,488 |
| ZtlidoLidocaine | 15 | $9,766 |
| Gabapentin | 1,072 | $9,045 |
| Pregabalin | 390 | $7,797 |
| Hydrocodone Bitartrate ErHydrocodone Bitartrate | 13 | $6,188 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $2,672 | $90,108132 claims |
| Redhill Biopharma Inc.Movantik | $120 | $38,73893 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $1,138 | $30,27412 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $885 | $9,76615 claims |
| Virtus Pharmaceuticals LLCLactulose | $17 | $41251 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 294 pain medicine providers in Pennsylvania.
Other pain medicine in Spring House
- Peter PryzbylkowskiPhiladelphia$506K
- Yeshvant NavalgundGreensburg$388K
- Jack SmithWilliamsport$324K
- Sanjay GuptaBala Cynwyd$241K
- Vwaire OrhurhuWilliamsport$191K
- Philip KimBryn Mawr$128K
- Ajay WasanPittsburgh$66K
- Soon JungAllentown$58K
- Bruce NicholsonAllentown$58K
- Jonathan BeattyPhiladelphia$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.